LOGIN
Iron combined with recombinant human erythropoietin: reduces anemia following TKA surgery
August 2014
Iron combined with recombinant human erythropoietin: reduces anemia following TKA surgery
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty
Transfusion. 2011 Jan;51(1):118-24Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
113 female patients, who were iron-deficient and scheduled for bilateral TKA were randomly assigned to 1 of 2 treatment groups to test the effectiveness of a combination of iron serum and recombinant human erythropoietin (rHuEPO) on reducing postoperative anemia and the need for transfusion. During the TKS surgery, subjects in the intervention group were administered iron and rHuEPO, while those i...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.